Arteris director granted 4,703 RSUs

Chitkara Raman reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Chitkara Raman reported acquisition or exercise transactions in this Form 4 filing.

Arteris director Raman Chitkara reported an equity award of 4,703 shares of common stock in the form of restricted stock units (RSUs). The RSUs were granted at no cash cost and will vest in full on the earlier of the first anniversary of the June 2, 2026 grant date or immediately before the next annual stockholder meeting, contingent on continued Board service. Following this award, Chitkara directly holds 147,570 shares, and has elected to defer receipt of the underlying shares once the RSUs vest.

Insider Trade Summary

Grant/Award: 4,703 shares

Grant/Award 1 txn

Insider Chitkara Raman

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,703	$0.00	$0.00

Holdings After Transaction: Common Stock — 147,570 shares (Direct)

Footnotes (2)

1. F1. Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89.
2. F2. The Reporting Person elected to defer the receipt of shares.

Key Figures

RSU grant size: 4,703 RSUs Holdings after transaction: 147,570 shares Reference average trading price: $31.89 +1 more

4 metrics

RSU grant size 4,703 RSUs Restricted stock unit award to director on June 2, 2026

Holdings after transaction 147,570 shares Total Arteris common stock directly held after RSU grant

Reference average trading price $31.89 Average Arteris common stock price from April 21, 2026 through June 2, 2026 used for grant

Transaction code A (Grant, award, or other acquisition) Indicates equity award rather than an open-market purchase or sale

Key Terms

restricted stock units ("RSUs"), vest in full, annual meeting of the Issuer's stockholders, elected to defer the receipt of shares

4 terms

restricted stock units ("RSUs") financial

"Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"The RSUs will vest in full on the earlier of (i) the first anniversary"

annual meeting of the Issuer's stockholders regulatory

"immediately before the annual meeting of the Issuer's stockholders following the grant date"

elected to defer the receipt of shares financial

"The Reporting Person elected to defer the receipt of shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Arteris (AIP) report for Raman Chitkara?

Arteris reported a grant of 4,703 restricted stock units to director Raman Chitkara. Each RSU represents one share of common stock, increasing his direct holdings to 147,570 shares after the award.

How many Arteris (AIP) shares does Raman Chitkara hold after this Form 4?

After the reported RSU award, Raman Chitkara holds 147,570 Arteris common shares. This total includes 4,703 restricted stock units that convert into shares upon vesting, subject to his continued Board service.

What are the vesting terms of Raman Chitkara’s 4,703 RSUs at Arteris (AIP)?

The 4,703 RSUs vest in full on the earlier of the first anniversary of the June 2, 2026 grant date or immediately before the next annual stockholder meeting, assuming Chitkara continues to serve on Arteris’s Board through that date.

Was there a purchase price for Raman Chitkara’s new Arteris (AIP) RSUs?

The RSUs were granted at no cash purchase price to Raman Chitkara. The grant value was based on Arteris’s average trading price of $31.89 from April 21, 2026 through June 2, 2026, as described in the footnote.

Did Raman Chitkara defer receipt of the Arteris (AIP) RSU shares?

Yes. A footnote states that Raman Chitkara elected to defer receipt of the shares underlying his 4,703 RSUs. He will receive the shares after vesting according to the deferral terms instead of immediately at vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 06:59 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chitkara Raman

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		A		4,703(1)(2)	A	$0.00	147,570	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89.

2. The Reporting Person elected to defer the receipt of shares.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Chitkara Raman	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)